The other highly significant progress made in recent years concerns a growing understanding of the molecular pathways involved in PD pathogenesis—primarily driven by unravelling the genetic architecture of PD.
← all excerpts
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
1
—
—